Organix, Inc.
Records under this name other than the patents Organix, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,893,260 | Substituted QUINAZOLIN-4-ONE Compounds for Antagonizing TRPV3 Function Formerly held In force · High confidence | In force | High confidence | |
| US 9,173,950 | Vitamin D-ghrelin conjugates Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,289,507 | Carriers for improved drug delivery Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,884,124 | Carriers for improved drug delivery Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,585,934 | Therapeutic vitamin D conjugates Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,616,109 | Insulin vitamin D conjugates Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,789,197 | RNAi vitamin D conjugates Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,406,202 | Therapeutic vitamin D conjugates Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,420,819 | Insulin vitamin D conjugates Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,116,816 | Therapeutic vitamin d conjugates Formerly held In force · From the USPTO record | In force | From the USPTO record |